Trait
Enlarged clitoris
Clinical name: Clitoral hypertrophy
Hypertrophy of the clitoris.
Summary
- Also called
- Clitoral enlargement, Clitoromegaly, Hypertrophic clitoris, Prominent clitoris
- Body system
- Abnormality of the genitourinary system
Reference genomeGRCh38hg38
Positions on gene and variant pages follow this choice, in this browser.
Read the genes linked to Enlarged clitoris, and the rest of your genome, with one test.
From $449Free shipping · Results in 6–8 weeks
Get my Genome Test69 genes linked to Enlarged clitoris
Changes in these genes cause rare conditions in which Enlarged clitoris is seen. Most people with this trait have none of those conditions, and a gene on this list says nothing about anyone's own genome.
| Gene | How often it is seen | Conditions |
|---|---|---|
| ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Always | In 2 conditions |
| CACHD1cache domain containing 1 | Always | In 1 condition |
| DONSONDNA replication fork stabilization factor DONSON | Always | In 1 condition |
| FDXRferredoxin reductase | Always | In 2 conditions |
| FGFR2fibroblast growth factor receptor 2 | Always | In 2 conditions |
| INSRinsulin receptor | Always | In 4 conditions |
| DHX37DEAH-box helicase 37 | Very often (80–99%) | In 1 condition |
| GATA4GATA binding protein 4 | Very often (80–99%) | In 1 condition |
| HSD17B3hydroxysteroid 17-beta dehydrogenase 3 | Very often (80–99%) | In 1 condition |
| KAT6Blysine acetyltransferase 6B | Very often (80–99%) | In 2 conditions |
| MAP3K1mitogen-activated protein kinase kinase kinase 1 | Very often (80–99%) | In 2 conditions |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Very often (80–99%) | In 1 condition |
| NR5A1nuclear receptor subfamily 5 group A member 1 | Very often (80–99%) | In 4 conditions |
| SOX9SRY-box transcription factor 9 | Very often (80–99%) | In 1 condition |
| SRYsex determining region Y | Very often (80–99%) | In 2 conditions |
| VAMP7vesicle associated membrane protein 7 | Very often (80–99%) | In 1 condition |
| WT1WT1 transcription factor | Very often (80–99%) | In 1 condition |
| WWOXWW domain containing oxidoreductase | Very often (80–99%) | In 1 condition |
| ZFPM2zinc finger protein, FOG family member 2 | Very often (80–99%) | In 1 condition |
| CCNQcyclin Q | Often (30–79%) | In 2 conditions |
| CDC45cell division cycle 45 | Often (30–79%) | In 2 conditions |
| CDC6cell division cycle 6 | Often (30–79%) | In 1 condition |
| CDT1chromatin licensing and DNA replication factor 1 | Often (30–79%) | In 1 condition |
| CEP152centrosomal protein 152 | Often (30–79%) | In 1 condition |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Often (30–79%) | In 2 conditions |
| DHCR77-dehydrocholesterol reductase | Often (30–79%) | In 1 condition |
| ESCO2establishment of sister chromatid cohesion N-acetyltransferase 2 | Often (30–79%) | In 2 conditions |
| GMNNgeminin DNA replication inhibitor | Often (30–79%) | In 1 condition |
| HSD3B2hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Often (30–79%) | In 1 condition |
| MED25mediator complex subunit 25 | Often (30–79%) | In 1 condition |
| ORC1origin recognition complex subunit 1 | Often (30–79%) | In 2 conditions |
| ORC4origin recognition complex subunit 4 | Often (30–79%) | In 2 conditions |
| ORC6origin recognition complex subunit 6 | Often (30–79%) | In 2 conditions |
| PEX1peroxisomal biogenesis factor 1 | Often (30–79%) | In 2 conditions |
| PEX10peroxisomal biogenesis factor 10 | Often (30–79%) | In 1 condition |
| PEX11Bperoxisomal biogenesis factor 11 beta | Often (30–79%) | In 1 condition |
| PEX12peroxisomal biogenesis factor 12 | Often (30–79%) | In 1 condition |
| PEX13peroxisomal biogenesis factor 13 | Often (30–79%) | In 1 condition |
| PEX14peroxisomal biogenesis factor 14 | Often (30–79%) | In 1 condition |
| PEX16peroxisomal biogenesis factor 16 | Often (30–79%) | In 1 condition |
Show 29 more genes
| Gene | How often it is seen | Conditions |
|---|---|---|
| PEX19peroxisomal biogenesis factor 19 | Often (30–79%) | In 1 condition |
| PEX2peroxisomal biogenesis factor 2 | Often (30–79%) | In 2 conditions |
| PEX26peroxisomal biogenesis factor 26 | Often (30–79%) | In 1 condition |
| PEX3peroxisomal biogenesis factor 3 | Often (30–79%) | In 1 condition |
| PEX5peroxisomal biogenesis factor 5 | Often (30–79%) | In 2 conditions |
| PEX6peroxisomal biogenesis factor 6 | Often (30–79%) | In 1 condition |
| PORcytochrome p450 oxidoreductase | Often (30–79%) | In 1 condition |
| TOP2BDNA topoisomerase II beta | Often (30–79%) | In 1 condition |
| ARandrogen receptor | Sometimes (5–29%) | In 1 condition |
| ARID1BAT-rich interaction domain 1B | Sometimes (5–29%) | In 1 condition |
| COX7Bcytochrome c oxidase subunit 7B | Sometimes (5–29%) | In 2 conditions |
| CYP11A1cytochrome P450 family 11 subfamily A member 1 | Sometimes (5–29%) | In 2 conditions |
| FIG4FIG4 phosphoinositide 5-phosphatase | Sometimes (5–29%) | In 1 condition |
| GAD1glutamate decarboxylase 1 | Sometimes (5–29%) | In 1 condition |
| HCCSholocytochrome c synthase | Sometimes (5–29%) | In 2 conditions |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Sometimes (5–29%) | In 2 conditions |
| PPP1R12Aprotein phosphatase 1 regulatory subunit 12A | Sometimes (5–29%) | In 1 condition |
| TOE1target of EGR1, exonuclease | Sometimes (5–29%) | In 1 condition |
| UBE3Bubiquitin protein ligase E3B | Sometimes (5–29%) | In 2 conditions |
| VAC14VAC14 component of PIKFYVE complex | Sometimes (5–29%) | In 1 condition |
| AGPAT21-acylglycerol-3-phosphate O-acyltransferase 2 | Not recorded | In 1 condition |
| ATRATR checkpoint kinase | Not recorded | In 1 condition |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Not recorded | In 1 condition |
| CD96CD96 molecule | Not recorded | In 1 condition |
| FRAS1Fraser extracellular matrix complex subunit 1 | Not recorded | In 1 condition |
| RSPO1R-spondin 1 | Not recorded | In 1 condition |
| TALDO1transaldolase 1 | Not recorded | In 1 condition |
| TRAIPTRAF interacting protein | Not recorded | In 1 condition |
| UBR1ubiquitin protein ligase E3 component n-recognin 1 | Not recorded | In 1 condition |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Broader traits
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the trait, its names, its definition and the genes linked to it. Find out more at hpo.jax.org.
- Data release 2026.10.16-c6eea6bf.
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks